Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-016560

Chief Commercial Officer sold 3,826 shares at an average $90.02 ($344,432)

  • Chief Commercial Officer acquired 3,826 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-14 Exercise or conversion : show line 1 in the form 10b5-1 +3,050 $16.00 $48,800 17,425 D
2024-02-14 Sale : show line 2 in the form 10b5-1 −3,050 $90.03 $274,592 14,375 D
2024-02-15 Exercise or conversion : show line 3 in the form 10b5-1 +776 $16.00 $12,416 15,151 D
2024-02-15 Sale : show line 4 in the form 10b5-1 −776 $90.00 $69,840 14,375 D
Open-market sales · 3,826 sh · avg $90.02 · $344,432

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-14 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −3,050 1,920 D
2024-02-15 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −776 1,144 D
Loading xslF345X05/ownership.xml…